Infinity Pharmaceuticals | INFI - Market Capitalization


Infinity Pharmaceuticals reported $0 in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Alterity Therapeutics Limited AUD 11M 5M Jun/2023
Amgen USD 201.45B 25.2B Feb/2026
AstraZeneca USD 222.33B 65.82B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 47.99M 4.37M Jan/2026
Compugen USD 137.5M 21.89M Sep/2025
CSL USD 76.3B 60.04B Jun/2025
Eisai JPY 1.43T 119.2B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Grifols EUR 6.77B 773M Sep/2025
Incyte USD 22.7B 3.31B Feb/2026
Infinity Pharmaceuticals USD 19M 5M Jun/2023
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 5.74B 21M Sep/2025